These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3088271)

  • 1. Effects of oral contraceptives on cholesterol.
    Roy S
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-8. PubMed ID: 3088271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
    Briggs MH
    J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of triglycerides in female rats and guinea pigs treated with steroid contraceptives.
    Kumar AM; Chakravarti RN; Kumar M
    Indian J Exp Biol; 1986 Dec; 24(12):789-90. PubMed ID: 3583335
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
    Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of oral contraceptive preparations and smoking on lipoprotein repartition].
    Foulon T; Payen N; Groslambert P; Bijaoui S; Dupont G; Roland F; Laporte F
    Ann Biol Clin (Paris); 1999; 57(5):573-8. PubMed ID: 10518059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein alterations from a triphasic oral contraceptive containing ethinyl estradiol and gestodene. A 12-month trial.
    Moutos DM; Zacur HA; Bachorik PS; Wallach EE
    J Reprod Med; 1994 Sep; 39(9):720-4. PubMed ID: 7807486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of long-term use of composite steroid contraceptives on serum lipids in women].
    Li ZX
    Zhonghua Fu Chan Ke Za Zhi; 1983 Apr; 18(2):98-100. PubMed ID: 6628082
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of contraceptive steroids on plasma lipoprotein metabolism in female rats (II).
    Köse K; Doğan P; Ozesmi C
    Biochem Mol Biol Int; 1993 Jun; 30(2):245-52. PubMed ID: 8364406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral (combination and progestogen alone) and injectable contraceptives on serum copper levels.
    Donde UM; Virkar K
    Indian J Med Res; 1976 Jun; 64(6):787-91. PubMed ID: 977035
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipoprotein and apoprotein A1 levels in diabetics and coronary heart disease patients and controls.
    Pan XR; Hu SX; Gang Y; Jin L; Li XG; Li J; Yan Q; Chen TS
    Chin Med J (Engl); 1987 Mar; 100(3):204-7. PubMed ID: 3113842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of hormonal contraceptives on parameters of lipid metabolism (author's transl)].
    Carol W; Klinger G
    Zentralbl Gynakol; 1980; 102(22):1273-82. PubMed ID: 6164181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives.
    Guazzelli CA; Lindsey PC; de Araújo FF; Barbieri M; Petta CA; Aldrighi JM
    Contraception; 2005 Feb; 71(2):118-21. PubMed ID: 15707561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiphasic oral contraceptives. Efficacy and metabolic impact.
    Ellis JW
    J Reprod Med; 1987 Jan; 32(1):28-36. PubMed ID: 3550064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.